A detailed history of Birchview Capital, LP transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 82,000 shares of KALV stock, worth $685,520. This represents 0.88% of its overall portfolio holdings.

Number of Shares
82,000
Previous 46,000 78.26%
Holding current value
$685,520
Previous $541,000 75.42%
% of portfolio
0.88%
Previous 0.54%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.46 - $15.39 $340,560 - $554,040
36,000 Added 78.26%
82,000 $949,000
Q1 2024

May 14, 2024

BUY
$11.07 - $16.04 $66,420 - $96,240
6,000 Added 15.0%
46,000 $545,000
Q1 2021

May 14, 2021

BUY
$14.69 - $42.57 $146,900 - $425,700
10,000 Added 33.33%
40,000 $1.03 Million
Q3 2019

Nov 12, 2019

BUY
$11.6 - $21.67 $348,000 - $650,100
30,000 New
30,000 $348,000

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $206M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.